Mohammad H. Morovati
Research Subjects
Mohammad H. Morovati has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alireza Hatami
Razi Vaccine and Serum Research Institute
1 shared publicationDavoud Sakhaei
Quality Control Management, Razi Vaccine and Serum Research Institute
1 shared publicationEdris Shirvani
Quality Control Management, Razi Vaccine and Serum Research Institute
1 shared publication- Hassan Morovati
Quality Control Management, Razi Vaccine and Serum Research Institute, PO Box 311975-148, Karaj, Iran
1 shared publication Masoume Bahreyari
Quality Control Management, Razi Vaccine and Serum Research Institute
1 shared publicationMohsen Lotfi
Quality Control Management, Razi Vaccine and Serum Research Institute
1 shared publication
Latest Publications
- 31 December 2011
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 44 (6) , 1127-1129
Seroprevalence of bovine leukemia virus (BLV) infection in dairy cattle in Isfahan Province, Iran
Bovine leukemia virus (BLV), the causative agent of enzootic bovine leukosis (EBL) is an exogenous C-type oncovirus in the Retroviridae family. It causes significant economic losses associated with the costs of control and eradication programs due to carcass condemnation at slaughter and restrictions of export of cattle and semen to importing countries. The main objective of this research was to determine the seroprevalence of BLV infection in cattle herds in central region of Iran (Isfahan province) using a commercial enzyme-linked immunosorbent assay (ELISA) to detect serum antibodies against BLV. Samples of blood serum were collected from 403 female dairy cattle (Holstein–Friesian) from 21 livestock farms and 303 animals (81.9%) were BLV seropositive. A significant association was found between age as a potential risk factor and BVL seroprevalence with animals ≥4 years (86.6%) having a significantly (χ 2 = 35.6, p < 0.001) higher seroprevalence compared to those 0.1). It is concluded that BLV infection is a very common problem in the study area. Hence, control measures should be instituted to combat the disease and further studies are required to investigate the impact of this disease on dairy production in the country.
- 31 December 2011
- Published by Springer Nature in Tropical Animal Health and Production
- Vol. 44 (6) , 1127-1129
Seroprevalence of bovine leukemia virus (BLV) infection in dairy cattle in Isfahan Province, Iran
Bovine leukemia virus (BLV), the causative agent of enzootic bovine leukosis (EBL) is an exogenous C-type oncovirus in the Retroviridae family. It causes significant economic losses associated with the costs of control and eradication programs due to carcass condemnation at slaughter and restrictions of export of cattle and semen to importing countries. The main objective of this research was to determine the seroprevalence of BLV infection in cattle herds in central region of Iran (Isfahan province) using a commercial enzyme-linked immunosorbent assay (ELISA) to detect serum antibodies against BLV. Samples of blood serum were collected from 403 female dairy cattle (Holstein–Friesian) from 21 livestock farms and 303 animals (81.9%) were BLV seropositive. A significant association was found between age as a potential risk factor and BVL seroprevalence with animals ≥4 years (86.6%) having a significantly (χ 2 = 35.6, p < 0.001) higher seroprevalence compared to those 0.1). It is concluded that BLV infection is a very common problem in the study area. Hence, control measures should be instituted to combat the disease and further studies are required to investigate the impact of this disease on dairy production in the country.